Keyphrases
Prostate Cancer
100%
Population-based Cohort
100%
Finnish Population
100%
Prostate Cancer Prognosis
100%
Antidiabetic Drugs
100%
Blood Glucose
42%
Metformin
28%
Androgen Deprivation Therapy
28%
Prostate Cancer Risk
28%
Medication Use
28%
Risk Increase
28%
Finland
14%
Separation Analysis
14%
Clinical Characteristics
14%
Multivariable
14%
Diabetes
14%
Insulin
14%
Simultaneous Use
14%
Type 2 Diabetes Mellitus (T2DM)
14%
Prognostic Factors
14%
Cox Regression
14%
Comorbidity
14%
Risk Factors
14%
Prescription Database
14%
Prostate Cancer Survival
14%
Risk Association
14%
Cancer Prognostics
14%
Drug Users
14%
Social Insurance
14%
Therapy Initiation
14%
Glycemic Control
14%
Multiple Drugs
14%
Cancer Onset
14%
Co-use
14%
Medicine and Dentistry
Prostate Cancer
100%
Cancer Prognosis
100%
Antidiabetic Agent
100%
Blood Glucose
27%
Cancer Mortality
18%
Diabetes
18%
Androgen Deprivation Therapy
18%
Glycon
18%
Prognostic Factor
9%
Proportional Hazards Model
9%
Cohort Analysis
9%
Prostate Cancer Survival
9%
Glycemic Control
9%
Anti-Diabetic Medication
9%
Comorbidity
9%
Pharmacology, Toxicology and Pharmaceutical Science
Prostate Cancer
100%
Cancer Prognosis
100%
Antidiabetic Agent
100%
Androgen
16%
Cancer Mortality
16%
Metformin
16%
Cohort Study
8%
Cancer Survival
8%
Anti-Diabetic Medication
8%
Comorbidity
8%
Biochemistry, Genetics and Molecular Biology
Glucose Blood Level
100%
Cancer Mortality
66%
Cohort Study
33%
Cancer Survival
33%
Glycemic Control
33%
Comorbidity
33%